Sirona Biochem Corp. announced the appointment of David Moore to its Board of Directors. David joins the board of directors with significant biotech and big pharma experience.
David is currently Chief Commercial Officer of Cempra.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.05 CAD | +25.00% |
|
0.00% | -58.33% |
06-20 | Sirona Biochem Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024 | CI |
05-07 | Sirona Biochem Engages Stonegate Healthcare Partners | CI |
Sirona Biochem Corp. announced the appointment of David Moore to its Board of Directors. David joins the board of directors with significant biotech and big pharma experience.
David is currently Chief Commercial Officer of Cempra.
1st Jan change | Capi. | |
---|---|---|
-58.33% | 9.42M | |
+16.59% | 44.44B | |
-10.62% | 37.68B | |
+41.36% | 39.84B | |
+29.92% | 31.46B | |
-9.78% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |